Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. (SYRS) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001556263 · SYRS · OTC · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001556263 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Syros Pharmaceuticals, Inc. (OTC: SYRS) has submitted 682 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2016. As a Healthcare sector company with CIK 0001556263, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Syros Pharmaceuticals, Inc.'s most comprehensive regulatory disclosure. The most recent Syros Pharmaceuticals, Inc. 10-K was filed on 2024-03-27 for fiscal year ending 2024. Historical SYRS 10-K annual reports are available from 2012 through 2024.
Investors researching Syros Pharmaceuticals, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
SYRS SEC Filings · 8 questionsSyros Pharmaceuticals, Inc. (SYRS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 682 filings and access original documents at no cost. Syros Pharmaceuticals, Inc.'s CIK is 0001556263.